IDH1 Mutation Myeloid Neoplasms
2 clinical trials · Condition
◉ Watch IDH1 Mutation Myeloid Neoplasms
| Record | Firm | Date |
|---|---|---|
| Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia (NCT04250051) | Northwestern University | 2020-12-21 |
| IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation (NCT03564821) | Massachusetts General Hospital | 2019-01-16 |
Track IDH1 Mutation Myeloid Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.